The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...

Cipla has launched inhaled insulin powder in India, providing a needle-free alternative for diabetes patients. Approved by CDSCO, Afrezza offers a convenient way to manage diabetes, especially for ...

WANNABE slimmers were today urged not to suddenly restart fat jabs at the same dose after pressing pause over Christmas.

The insulin inhalation powder in Afrezza is available in single-use cartridges and is delivered via an inhaler device.

PreEvnt’s isaac system enters human clinical trials, bringing non-invasive, breath-based glucose monitoring closer to a late ...

India’s Cipla Limited (BSE: 500087) announced the launch of Afrezza (insulin human) Inhalation Powder in India.

A published case series reports unexpected cancer remissions linked with fenbendazole use, prompting renewed discussion on repurposed drugs and the need for clinical trials.

DUBBED the “Godzilla” of fat jabs, they are the groundbreaking weight loss injectables said to help slimmers shed a quarter ...

Nandita Vijayasimha, Bengaluru Friday, January 2, 2026, 08:00 Hrs [IST] ...

The Best Weight Loss Supplements for Women This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: The best ...

Ozempic and Rybelsus both treat diabetes and cause weight loss, but Ozempic is an injection and Rybelsus is a pill.

Baystreet.ca News Commentary – Pharmaceutical markets are witnessing drug delivery devices surge toward $862.16 billion by ...